KOVALCHUK, SOFYA
 Distribuzione geografica
Continente #
NA - Nord America 2.227
EU - Europa 1.415
AS - Asia 794
SA - Sud America 113
AF - Africa 24
OC - Oceania 6
Totale 4.579
Nazione #
US - Stati Uniti d'America 2.200
RU - Federazione Russa 570
IT - Italia 248
SG - Singapore 217
HK - Hong Kong 182
PL - Polonia 172
CN - Cina 164
IE - Irlanda 123
BR - Brasile 91
DE - Germania 78
SE - Svezia 72
KR - Corea 65
CH - Svizzera 43
VN - Vietnam 43
FI - Finlandia 36
IN - India 36
GB - Regno Unito 27
JO - Giordania 21
CA - Canada 19
ID - Indonesia 12
NL - Olanda 10
FR - Francia 9
AR - Argentina 8
JP - Giappone 8
TR - Turchia 8
MA - Marocco 7
ZA - Sudafrica 7
AU - Australia 6
AT - Austria 5
CI - Costa d'Avorio 5
MX - Messico 5
UA - Ucraina 5
UZ - Uzbekistan 5
BD - Bangladesh 4
EC - Ecuador 4
PK - Pakistan 4
VE - Venezuela 4
ES - Italia 3
IQ - Iraq 3
PH - Filippine 3
TJ - Tagikistan 3
AZ - Azerbaigian 2
BE - Belgio 2
BY - Bielorussia 2
CO - Colombia 2
EG - Egitto 2
GE - Georgia 2
MY - Malesia 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BJ - Benin 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
IR - Iran 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LT - Lituania 1
MM - Myanmar 1
NO - Norvegia 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.579
Città #
Santa Clara 613
Ashburn 247
Fairfield 181
Warsaw 169
Hong Kong 151
Singapore 125
Dublin 123
Woodbridge 107
Chandler 103
Houston 90
Seattle 89
Cambridge 84
Wilmington 61
Ann Arbor 60
Seoul 60
Beijing 59
Moscow 42
Munich 42
Bern 40
Florence 34
Altamura 29
Boston 29
Lawrence 28
Princeton 27
Buffalo 25
Los Angeles 25
Mumbai 23
Shanghai 21
New York 19
Milan 17
Dallas 15
Helsinki 14
Hefei 13
Lappeenranta 13
Hanoi 10
San Diego 10
The Dalles 10
Dearborn 9
Medford 9
Rome 9
São Paulo 9
Toronto 9
Clifton 8
Dong Ket 8
Falkenstein 8
Ho Chi Minh City 8
Jakarta 8
Kent 8
Boardman 7
Paris 7
Turku 7
Bologna 6
Denver 6
London 6
Union City 6
Abidjan 5
Johannesburg 5
Melbourne 5
Naples 5
Norwalk 5
Pisa 5
Redwood City 5
Secaucus 5
Sesto Fiorentino 5
Boydton 4
Bremen 4
Canton 4
Chennai 4
Curitiba 4
Guangzhou 4
Montreal 4
Nuremberg 4
Thiene 4
Tianjin 4
Turin 4
Yubileyny 4
Gangdong-gu 3
Hounslow 3
Hải Dương 3
Istanbul 3
Olgiate Olona 3
Orem 3
Osaka 3
Phoenix 3
Poplar 3
Pune 3
Redondo Beach 3
Rozzano 3
Salerno 3
Stockholm 3
Tashkent 3
Verona 3
Amman 2
Baku 2
Bergamo 2
Bocale 2
Brescia 2
Brooklyn 2
Brussels 2
Casablanca 2
Totale 3.103
Nome #
The use of Deauville 5-point score could reduce the risk of false-positive fluorodeoxyglucose-positron emission tomography in the posttherapy evaluation of patients with primary bone lymphomas 245
THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI: A PROSPECTIVE COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) OF 1353 ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA 235
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 235
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study 223
The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study 221
RESPONSE ORIENTED MAINTENANCE THERAPY IN ADVANCED FOLLICULAR LYMPHOMA. RESULTS OF THE INTERIM ANALYSIS OF THE FOLL12 TRIAL CONDUCTED BY THE FONDAZIONE ITALIANA LINFOMI 215
DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA (HD): RESULTS OF A PHASE II, PROSPECTIVE STUDY BY FONDAZIONE ITALIANA LINFOMI 194
Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: Interobserver agreement and reproducibility across software platforms 187
Safety Profile of Idelalisib in Patients with Refractory Follicular Lymphoma: Interim Analysis of a Noninterventional Study 183
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity 180
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 176
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study 172
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 167
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 167
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 166
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma 164
CLINICAL CHARACTERISTICS OF PATIENTS WITH NEGATIVE INTERIM-PET AND POSITIVE FINAL PET: DATA FROM THE PROSPECTIVE PET-ORIENTED HD0801 STUDY BY FONDAZIONE ITALIANA LINFOMI (FIL) 162
A gene expression-based model to predict metabolic response after two courses of ABVD in Hodgkin Lymphoma patients 162
Multicenter Long Term Follow-up in Hairy Cell Leukemia Patients Treated with Cladribine: A Thirty-Year Experience 157
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) 153
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 152
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen 149
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 146
Long-Term results of the FOLL05 trial comparing R-CVP Versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage symptomatic follicular lymphoma 143
Complete remission with brentuximab vedotin in a case of primary cutaneous gamma-delta T-cell lymphoma relapsed after allogeneic stem cell transplantation 133
Treatment and prognosis of primary pulmonary lymphoma: a long-term follow-up study 128
Totale 4.615
Categoria #
all - tutte 12.755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.755


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021322 0 0 0 0 0 35 34 57 47 69 37 43
2021/2022191 2 13 23 16 6 10 8 11 16 10 23 53
2022/2023556 40 77 38 28 30 94 67 28 66 4 15 69
2023/2024313 8 28 32 10 32 39 24 54 11 34 25 16
2024/20251.652 42 146 88 276 496 264 17 94 78 41 49 61
2025/2026843 216 192 99 116 204 16 0 0 0 0 0 0
Totale 4.615